Recent Episodes
A Deep Dive into Myelofibrosis
Srdan Verstovsek, MD, PhD, MD Anderson Cancer Center, Houston, TX
Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia: Part I
Jacqueline C. Barrientos, MD, MS, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
CAR T-cell Therapy in 2022: What You Need to Know
Caron Jacobson, MD, Dana-Farber Cancer Institute, Boston, MA
Highpoints from Attending the 2021 American Society of Hematology Conference
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Updates on COVID-19 in Patients with Blood Cancer
John P. Leonard, MD, Weill Cornell Medicine, New York Presbyterian, New York, NY
A Conversation on Adult Survivorship
Maria Alma Rodriguez, MD, MACP, CMQ, The University of Texas MD Anderson Cancer Center, Houston, TX
Categories
- All Episodes (94)
- CAR T-cell Therapy (11)
- Clinical Trials (4)
- COVID-19 (7)
- General Treatment & Support (31)
- Genomics (3)
- Health Equity (8)
- Leukemia (22)
- Lymphoma (15)
- Minimal Residual Disease (MRD) (4)
- Myelodysplastic Syndromes (5)
- Myeloma & Amyloidosis (13)
- Myeloproliferative Neoplasms (3)
- Pediatric and AYA (12)
- Rare Blood Cancers (4)
- Transplantation (4)
- Waldenström macroglobulinemia (2)